Effects of phenothiazine treatment on the physical properties of platelet membranes from psychiatric patients.
Exposure of normal platelet membranes in vitro to clinically relevant concentrations of phenothiazines has been reported to result in an increase in the structural order of the hydrocarbon region of these membranes (Zubenko and Cohen 1984b,c). In this study, the order parameters (reciprocal of fluidity) of platelet membranes prepared from psychiatric patients receiving phenothiazine antipsychotic drugs were compared to those of an otherwise matched population of psychiatric patients who were not receiving medications that significantly affect this cell membrane property in vitro (Zubenko and Cohen 1984b,c). Membrane order was determined ex vivo by steady-state fluorescence polarization measurements employing 1,6-diphenyl 1,3,5-hexatriene, a fluorescent probe that localizes preferentially in the hydrocarbon region of cell membranes. Phenothiazine administration was associated with a significant increase in platelet membrane order and most likely results from a direct action of these agents on cell membranes. The platelet membrane order parameters of phenothiazine-free patients did not differ significantly from those of a matched group of unmedicated, normal controls. Platelet membrane order was not correlated with daily phenothiazine dose or serum cholesterol concentration. Patient gender did not significantly affect platelet membrane order in any of the groups studied. The potential physiological and clinical significance of phenothiazine-induced increases in cell membrane order is discussed.
Zubenko
G S
GS
Cohen
B M
BM
D000328:Adult; D000367:Age Factors; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy; D001792:Blood Platelets / Q000187:drug effects*; D001883:Borderline Personality Disorder / Q000188:drug therapy; D002462:Cell Membrane / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D003866:Depressive Disorder / Q000188:drug therapy; D005260:Female; D005454:Fluorescence Polarization; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy; D008297:Male; D001523:Mental Disorders / Q000097:blood / Q000188:drug therapy*; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy; D010640:Phenothiazines; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D010640:Phenothiazines; D002784:Cholesterol